Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX0MV8
|
||||
Drug Name |
SID85147302
|
||||
Synonyms |
CHEMBL567134
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C14H10F2N6
|
||||
Canonical SMILES |
CCNc1nc(nc2c1ncn2c3cc(F)cc(F)c3)C#N
|
||||
InChI |
InChI=1S/C14H10F2N6/c1-2-18-13-12-14(21-11(6-17)20-13)22(7-19-12)10-4-8(15)3-9(16)5-10/h3-5,7H,2H2,1H3,(H,18,20,21)
|
||||
InChIKey |
VLZYXSQGILGQAI-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.